Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Gastroenteritis; Rotavirus Infections | Phase 3 | ClinicalTrials |
| Streptococcal Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 2 | ClinicalTrials |
| Diarrhea; Nausea | Phase 2 | ClinicalTrials |
| Diarrhea; Intestinal Diseases; Sprue, Tropical | Phase 3 | ClinicalTrials |
| Poliomyelitis | Phase 4 | ClinicalTrials |
| Streptococcal Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 2 | ClinicalTrials |
| Diphtheria; Tetanus; Whooping Cough | Phase 4 | ClinicalTrials |
| Diphtheria; Hepatitis B; Poliomyelitis | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
| Meningococcal Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
| Streptococcal Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
| Hepatitis B | Phase 2 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
| Rotavirus Infections | Phase 3 | ClinicalTrials |
CONTENTS